Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Acquisitions & Divestments: 2023-2025

Historic Change in Acquisitions & Divestments for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $72.7 million.

  • Upstream Bio's Change in Acquisitions & Divestments fell 3.23% to $72.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $279.6 million, marking a year-over-year increase of 58.06%. This contributed to the annual value of $231.6 million for FY2024, which is 400.38% up from last year.
  • Upstream Bio's Change in Acquisitions & Divestments amounted to $72.7 million in Q3 2025, which was up 4.01% from $69.9 million recorded in Q2 2025.
  • Upstream Bio's Change in Acquisitions & Divestments' 5-year high stood at $84.3 million during Q4 2024, with a 5-year trough of $29.6 million in Q4 2023.
  • For the 3-year period, Upstream Bio's Change in Acquisitions & Divestments averaged around $57.1 million, with its median value being $61.3 million (2025).
  • In the last 5 years, Upstream Bio's Change in Acquisitions & Divestments surged by 185.25% in 2024 and then dropped by 3.23% in 2025.
  • Over the past 3 years, Upstream Bio's Change in Acquisitions & Divestments (Quarterly) stood at $29.6 million in 2023, then skyrocketed by 185.25% to $84.3 million in 2024, then fell by 3.23% to $72.7 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $72.7 million for Q3 2025, versus $69.9 million for Q2 2025 and $52.7 million for Q1 2025.